| Diversified business groups and corporate refocusing in emerging economies RE Hoskisson, RA Johnson, L Tihanyi, RE White Journal of Management 31 (6), 941-965, 2005 | 288 | 2005 |
| A framework for understanding international diversification by business groups from emerging economies RE Hoskisson, H Kim, RE White, L Tihanyi " Theories of the Multinational Enterprise: Diversity, Complexity and …, 2004 | 81 | 2004 |
| Employment and market innovation in Chinese business group affiliated firms: The role of group control systems RE White, RE Hoskisson, DW Yiu, GD Bruton Management and Organization Review 4 (2), 225-256, 2008 | 70 | 2008 |
| Principal costs in initial public offerings T Dalziel, RE White, JD Arthurs Journal of Management Studies 48 (6), 1346-1364, 2011 | 50 | 2011 |
| Agricultural systems intensification and diversification through food legumes: technological and policy options D Byerlee, R White Linking research and marketing opportunities for pulses in the 21st Century …, 2000 | 49 | 2000 |
| Multiple agency theory: An emerging perspective on corporate governance RE Hoskisson, JD Arthurs, RE White, C Wyatt | 32 | 2013 |
| Information flows and topic modeling in corporate governance JD Kushkowski, CB Shrader, MH Anderson, RE White Journal of Documentation 76 (6), 1313-1339, 2020 | 21 | 2020 |
| Initially distracted: the influence of boards on agency costs in initial public offering (IPO) firms T Dalziel, RE White, JD Arthurs, RE Hoskisson New Frontiers in Entrepreneurship: Recognizing, Seizing, and Executing …, 2010 | 10 | 2010 |
| An investigation into the key drivers influencing the decision making of the Scottish Medicines Consortium I Mshelia, R White, SR Mukku Value in Health 16 (3), A264, 2013 | 7 | 2013 |
| ANTIPSYCHOTIC COMPLIANCE EVALUATION—A POPULATION-BASED, MANAGED-CARE STUDY OF PERSISTENCE WITH INITIALLY PRESCRIBED ANTIPSYCHOTIC MEDICATION NJ Hills, DE Wilmington | 6 | 2001 |
| Geographic distance, firm affiliations, and IPO performance: evidence from China JP Berns, J Zhang, RE White Venture Capital 23 (1), 41-66, 2021 | 5 | 2021 |
| PHP116 Orphan Drug Pricing and Access–Current Situation and Future Trends in EU M Jeffery, R White Value in Health 15 (7), A309, 2012 | 3 | 2012 |
| Interlaboratory quality assurance aspects of the International Joint Commission's Great Lakes monitoring programs KI Aspila, JL Clark, RE White ASTM International, 1985 | 3 | 1985 |
| Geographic Distance and IPO Underpricing: The Impact of Firm Associations J Berns, RE White, J Zhang Academy of Management Proceedings 2014 (1), 16903, 2014 | 2 | 2014 |
| SHALL WE DANCE? THE ROLE OF AGENTS IN MANAGING THE PRINCIPAL-AGENT RELATIONSHIP. RE White Academy of Management Proceedings 2010 (1), 1-6, 2010 | 2 | 2010 |
| Toward a More Robust Theory of Agency: Three Corporate Governance Essays RE White Arizona State University, 2000 | 2 | 2000 |
| Data Quality Assurance for Watershed and Land Use Studies International Reference Group on Great Lakes Pollution from Land Use Activities | 2 | 1975 |
| Switching to riociguat in patients with pulmonary arterial hypertension not at treatment goal with phosphodiesterase type-5 inhibitors: subgroup analysis results of the replace … M Hoeper, H Ghofrani, H Al-Hiti, R Benza, SA Chang, P Corris, JS Gibbs, ... Chest 158 (4), A2156-A2159, 2020 | 1 | 2020 |
| Defining value when launching biosimilars treatments within European healthcare systems R White, O Staples Value in Health 18 (7), A535, 2015 | 1 | 2015 |
| PHP101 VALUE BASED PRICING: WHAT IS THE FUTURE FOR PATIENT ACCESS SCHEMES? CM Loveman, M Mallinson, T Areteou, R White Value in Health 14 (3), A30, 2011 | 1 | 2011 |
Jonathan ArthursAssociate ProfessorVerified email at bus.oregonstate.edu
